OncClubAll Oncology News
InsightsMedNews WeekOncChatsOncLive News Network®OncLive TVPeer ExchangePodcastsRapid Readouts
Conference CoverageConference Listing
Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars
PartnersPublications
Consensus ViewpointsOncLive AppInteractive ToolsSponsored
Biomarker ConsortiumSubscribe
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
Spotlight -
  • The OncLive Insider app is live!
  • CME Opportunities
Biosimilars
Brain Cancer
Breast CancerBreast Cancer
CAR T-cell Therapy
Disparities in Cancer Care
Gastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal CancerGastrointestinal Cancer
Genitourinary CancersGenitourinary CancersGenitourinary Cancers
Global Oncology
Gynecologic OncologyGynecologic Oncology
Head & Neck Cancers
Hematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic OncologyHematologic Oncology
Immuno-Oncology
Lung Cancer
Melanoma & Skin Cancer
Oncology Business Management
Pediatric Oncology
Precision Medicine in Oncology®
Sarcomas
Supportive Care
    • Partners
    • Publications
    • Biomarker Consortium
    • Subscribe

Your AI-Trained Oncology Knowledge Connection!

scout
Advertisement

Drs Leonard Gomella and Daniel Petrylak

home / news-network / gomella-petrylak
When to Image: Earlier?

EP. 1: When to Image: Earlier?

March 19th 2015
Looking Forward: Immunotherapy and Genomics

EP. 2: Looking Forward: Immunotherapy and Genomics

March 19th 2015
MAINSAIL: Lessons Learned

EP. 3: MAINSAIL: Lessons Learned

March 19th 2015
Abiraterone: Approval and Use

EP. 4: Abiraterone: Approval and Use

March 19th 2015
Sequencing: Important Question With Many Answers

EP. 5: Sequencing: Important Question With Many Answers

March 19th 2015
A Review of Bone-Targeted Therapies

EP. 6: A Review of Bone-Targeted Therapies

March 19th 2015
Changes in NCCN Guideline: Affecting Second-Line

EP. 7: Changes in NCCN Guideline: Affecting Second-Line

March 19th 2015
Sipuleucel-T: Evidence-based Use

EP. 8: Sipuleucel-T: Evidence-based Use

March 19th 2015
Considerations in Treatment Selection

EP. 9: Considerations in Treatment Selection

March 19th 2015
Changes in NCCN Guideline: Affecting First-Line

EP. 10: Changes in NCCN Guideline: Affecting First-Line

March 19th 2015
Prostate Cancer: Which Guidelines

EP. 11: Prostate Cancer: Which Guidelines

March 19th 2015

Latest Conference Coverage

Raludotatug Deruxtecan Shows Activity in Platinum-Sensitive Ovarian Cancer

Relacorilant/Nab-Paclitaxel Is Associated With Survival Improvement in Platinum-Resistant Ovarian Cancer After Short Platinum-Free Interval

PD-L1 CPS Does Not Enrich the Efficacy of Atezolizumab/Bevacizumab and Chemo in Advanced Cervical Cancer

BGB-16673 Displays a High ORR and Tolerability in Waldenström Macroglobulinemia

View More Latest Conference Coverage
Advertise
About OncLive
Editorial Board
MJH Life Sciences brands
Contact Us
Privacy
Terms & Conditions
Do Not Sell My Information
Contact Info

2 Commerce Drive
Cranbury, NJ 08512

609-716-7777

Download on Apple
© 2025 MJH Life Sciences

All rights reserved.
Home
About Us
News
Contact